1-4 of 4
Olivier Tournilhac
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Comprehensive Genetic Profiling Reveals Frequent Alterations of Driver Genes on the X Chromosome in Extranodal NK/T-cell Lymphoma

Yuta Ito, Amira Marouf, Yasunori Kogure, Junji Koya, Raphaël Liévin, Julie Bruneau, Mariko Tabata, Yuki Saito, Sumito Shingaki, Mitsuhiro Yuasa, Kentaro Yamaguchi, Koichi Murakami, Robert Weil, Manon Vavasseur, Guillaume P. Andrieu, Mehdi Latiri, Layla Veleanu, Michaël Dussiot, Isabelle André, Akshay Joshi, Chantal Lagresle-Peyrou, Aude Magerus, Sammara Chaubard, David Lavergne, Emmanuel Bachy, Erika Brunet, Virginie Fataccioli, Chantal Brouzes, Camille Laurent, Laurence de Leval, Alexandra Traverse-Glehen, Céline Bossard, Marie Parrens, Véronique Meignin, Laure Philippe, Julien Rossignol, Felipe Suarez, Jean-Marie Michot, Olivier Tournilhac, Gandhi Damaj, François Lemonnier, Christine Bôle-Feysot, Patrick Nitschké, Bruno Tesson, Cécile Laurent, Thierry Molina, Vahid Asnafi, Yosaku Watatani, Kenichi Chiba, Ai Okada, Yuichi Shiraishi, Sachiko Tsukita, Koji Izutsu, Hiroaki Miyoshi, Koichi Ohshima, Seiji Sakata, Akito Dobashi, Kengo Takeuchi, Masashi Sanada, Philippe Gaulard, Arnaud Jaccard, Seishi Ogawa, Olivier Hermine, Keisuke Kataoka, Lucile Couronné
Journal: Cancer Research
Cancer Res (2024) 84 (13): 2181–2201.
https://doi.org/10.1158/0008-5472.CAN-24-0132
Published: 02 July 2024
View article titled, Comprehensive Genetic Profiling Reveals Frequent Alterations of Driver Genes on the X Chromosome in Extranodal NK/T-cell Lymphoma
Open the PDF for Comprehensive Genetic Profiling Reveals Frequent Alterations of Driver Genes on the X Chromosome in Extranodal NK/T-cell Lymphoma in another window
Includes: Supplementary data
Journal Articles

Abstract CT022: Five-year efficacy and safety of tafasitamab in patients with relapsed or refractory DLBCL: Final results from the phase II L-MIND study

Johannes Duell, Pau Abrisqueta, Marc Andre, Marinela Augustin, Gianluca Gaidano, Eva González Barca, Wojciech Jurczak, Nagesh Kalakonda, Anna Marina Liberati, Kami J. Maddocks, Tobias Menne, Zsolt Nagy, Olivier Tournilhac, Abhishek Bakuli, Aasim Amin, Konstantin Gurbanov, Gilles Salles
Journal: Cancer Research
Cancer Res (2023) 83 (8_Supplement): CT022.
https://doi.org/10.1158/1538-7445.AM2023-CT022
Published: 14 April 2023
View article titled, Abstract CT022: Five-year efficacy and safety of tafasitamab in patients with relapsed or refractory DLBCL: Final results from the phase II L-MIND study
Journal Articles

Human Anti-CD40 Antagonist Antibody Triggers Significant Antitumor Activity against Human Multiple Myeloma

Yu-Tzu Tai, Xianfeng Li, Xia Tong, Daniel Santos, Takemi Otsuki, Laurence Catley, Olivier Tournilhac, Klaus Podar, Teru Hideshima, Robert Schlossman, Paul Richardson, Nikhil C. Munshi, Mohammad Luqman, Kenneth C. Anderson
Journal: Cancer Research
Cancer Res (2005) 65 (13): 5898–5906.
https://doi.org/10.1158/0008-5472.CAN-04-4125
Published: 01 July 2005
View article titled, Human Anti-CD40 Antagonist Antibody Triggers Significant Antitumor Activity against Human Multiple Myeloma
Open the PDF for Human Anti-CD40 Antagonist Antibody Triggers Significant Antitumor Activity against Human Multiple Myeloma in another window
Journal Articles

Human anti-CD40 antagonist antibody triggers significant antitumor activity against human multiple myeloma

Yu-Tzu Tai, Xian-Feng Li, Xia Tong, Daniel Santos, Laurence Catley Catley, Olivier Tournilhac Tournilhac, Takemi Otsuki, Klaus Podar, Teru Hideshima, Robert Schlossman, Paul Richardson, Munshi C. Munshi, Mohammad Luqman, Kenneth C. Anderson
Journal: Cancer Research
Cancer Res (2005) 65 (9_Supplement): 132.
Published: 01 May 2005
View article titled, Human anti-CD40 antagonist antibody triggers significant antitumor activity against human multiple myeloma